The toxicity of cisplatin on breast cancer MCF-7 cells was found to be increased by TRPV1-channel activation by alpha-lipoic acid (ALA), the effect of which was reversed by the TRPV1 blocker capsazepine 120. This evidence concerns the gene TRPV1 and breast carcinoma.